Hydromorphone Hydrochloride 31722-0122
Product NDC
31722-0122- Manufacturer
- Camber Pharmaceuticals, Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- September 24, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA212133
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hydromorphone Hydrochloride | 32 mg/1 |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Packaging Options(1)
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-122-01)